Karin Badel

2.1k citations
27 papers · 1.6k · h-index 14

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
  • Virology top 5%
    • HIV Research and Treatment

Papers in

  • Hematology 19
    • Hematopoietic Stem Cell Transplantation 15
    • Multiple Myeloma Research and Treatments 11
    • Acute Myeloid Leukemia Research 10
  • Oncology 6
    • Cancer Treatment and Pharmacology 2
Co-authors
Gary Calandra (13 shared papers)Gary Calandra (14 shared papers)Gary Bridger (6 shared papers)John F. DiPersio (3 shared papers)Daniel J. Weisdorf (4 shared papers)Jane L. Liesveld (3 shared papers)Neal Flomenberg (4 shared papers)Steven M. Devine (2 shared papers)
Journals
Blood (10 papers)Biology of Blood and Marrow Transplantation (7 papers)Bone Marrow Transplantation (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Journal of Clinical Oncology (1 paper)
Partner nations
United StatesCanadaGermany

In The Last Decade

Karin Badel

27 papers receiving 1.6k citations

Peers

Karin Badel
Comparison fields: 5 of 64
  • Hematology 922
  • Virology 131
  • Oncology 663
  • Immunology 532
  • Genetics 155
Replace Gary Calandra with:
Gary Calandra United States
Paulo Vidal Campregher Brazil
Harry R. Koene Netherlands
Sherrie E. Schiff United States
Hong Zheng United States
C. Gattringer Austria
Friedrich Schuening United States
Douglas Joshua Australia
Toni B. Simonis United States
Janet Ayello United States
Karin Badel relative to Gary Calandra United States Gary Calandra's profile →
Citations per field
00.5×1.5×
Gary Calandra · 1×
Citations per year

Countries citing papers authored by Karin Badel

Since Specialization
Citations

This map shows the geographic impact of Karin Badel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Badel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Badel more than expected).

Fields of papers citing papers by Karin Badel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Badel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Badel. The network helps show where Karin Badel may publish in the future.

Co-authors

The 25 scholars most cited alongside Karin Badel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karin Badel Line = papers co-authored together Karin Badel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Journal of Clinical Oncology ·Steven M. Devine, Neal Flomenberg, David H. Vesole, Jane L. Liesveld, Daniel J. Weisdorf, Karin Badel, Gary Calandra, John F. DiPersio
2004328
2
Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Craig W. Hendrix, Ann C. Collier, Michael M. Lederman, Dominique Schols, Richard B. Pollard, Stephen Brown, J. Brooks Jackson, Robert W. Coombs, Marshall J. Glesby, Charles Flexner, Gary Bridger, Karin Badel, R. T. MacFarland, Geoffrey Henson, Gary Calandra
2004285
3
AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
Bone Marrow Transplantation ·Gary Calandra, John M. McCarty, Joseph P. McGuirk, Guido Tricot, (unknown), Karin Badel, Birgith Engelst Grove, A Dye, Gary Bridger
2007221
4
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist
Transfusion ·W. Conrad Liles, Elin Rodger, Hal E. Broxmeyer, Christine Dehner, Karin Badel, Gary Calandra, Jeff Christensen, Brent L. Wood, Thomas H. Price, David C. Dale
2005177
5
A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma
Biology of Blood and Marrow Transplantation ·Amanda F. Cashen, Sandra Lopez, Feng Gao, Gary Calandra, Ron MacFarland, Karin Badel, John F. DiPersio
2008107
6
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization
Bone Marrow Transplantation ·Michael J. Dugan, Richard T. Maziarz, Jack W. Singer, Auayporn Nademanee, Jane L. Liesveld, Karin Badel, C. Dehner, Colleen Gibney, Gary Bridger, Gary Calandra
2009103
7
Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient
Biology of Blood and Marrow Transplantation ·Patrick J. Stiff, Ivana N. Micallef, Philip L. McCarthy, Margarida Magalhaes‐Silverman, Daniel J. Weisdorf, Mary Territo, Karin Badel, Gary Calandra
200986
8
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34 hematopoietic progenitor cells by AMD3100
Clinical Pharmacology & Therapeutics ·Nathan A. Lack, B. Green, David C. Dale, Gary Calandra, H. Lee, R. T. MacFarland, Karin Badel, W. Conrad Liles, Gary Bridger
200561
9
Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4‐Tropic HIV Type 1
Clinical Infectious Diseases ·Graeme Moyle, Edwin DeJesus, Marta Boffito, Rebecca S.Y. Wong, Colleen Gibney, Karin Badel, Ron MacFarland, Gary Calandra, Gary Bridger, Stephen Becker, (unknown)
200960
10
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
Bone Marrow Transplantation ·Stefan Früehauf, Gerhard Ehninger, Kai Hübel, Julian Topaly, Hartmut Goldschmidt, Anthony D. Ho, Simone Müller, M Moos, Karin Badel, Gary Calandra
200950
11
Improved Mobilization of Peripheral Blood CD34 + Cells and Dendritic Cells by AMD3100 plus Granulocyte–Colony-Stimulating Factor in Non-Hodgkin's Lymphoma Patients
Stem Cells and Development ·Yair Gazitt, César O. Freytes, Cagla Akay, Karin Badel, Gary Calandra
200743
12
Plerixafor (Mozobil®) Alone to Mobilize Hematopoietic Stem Cells from Multiple Myeloma Patients for Autologous Transplantation
Biology of Blood and Marrow Transplantation ·Neal Flomenberg, Raymond L. Comenzo, Karin Badel, Gary Calandra
201023
13
A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment
Biology of Blood and Marrow Transplantation ·R. T. MacFarland, Marjie Hard, Robert J. Scarborough, Karin Badel, Gary Calandra
200918
14
A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies.
Blood ·Steven M. Devine, Jesper Bonde, David A. Hess, Terri M. Edwards, Daniel C. Link, Diane S. Sempek, Gary Calandra, Karin Badel, Jan A. Nolta, John F. DiPersio
200414
15
Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.
Blood ·Michael J. Dugan, Luke P. Akard, James Thompson, Auayporn Nademanee, Richard T. Maziarz, William Bensinger, Jane L. Liesveld, Karin Badel, Christine Dehner, Colleen Gibney, Gary Calandra, Jan Jansen
20048
16
AMD3100 with G-CSF for Autologous Peripheral Blood Progenitor Cell (PBPC) Mobilization in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM): Mobilization, Engraftment, and Pharmacokinetics (PK).
Blood ·Stewart Douglas, Clayton A. Smith, R.T. McFarland, Karin Badel, Gary Calandra
20065
17
AMD3100 Combined with Standard Doses of G-Csf Leads to Rapid, Consistent Mobilization of Hematopoietic Progenitor Cells in Patients with Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma.
Blood ·Patrick J. Stiff, Ivana N. Micallef, Philip L. McCarthy, Margarida Magalhaes‐Silverman, Neal Flomenberg, Daniel J. Weisdorf, Guido Tricot, Mary Territo, Rafat Abonour, Karin Badel, Gary Calandra
20045
18
Pharmacokinetics of Plerixafor (AMD3100) in Volunteers with Renal Impairment.
Blood ·R. T. MacFarland, Reginal B. Ewesuedo, Karin Badel, Gary Calandra
20075
19
Steady State Mobilization of Autologous Blood Stem Cells Using G-CSF and AMD3100 in Patients with Multiple Myeloma (MM).
Blood ·Gerhard Ehninger, Stefan Früehauf, Kai Hübel, Uwe Platzbecker, Karin Badel, Gary Calandra
20064
20
15: AMD3100 plus G-CSF mobilizes the majority of non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), and Hodgkin’s disease (HD) patients who failed prior mobilization with other regimens
Biology of Blood and Marrow Transplantation ·Gary Calandra, John M. McCarty, Joseph P. McGuirk, Bart Barlogie, Sue-Anne Crocker, Karin Badel
20074

About Karin Badel

Karin Badel is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Immunology and Genetics, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), Multiple Myeloma Research and Treatments (11 papers), Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immune Cell Function and Interaction (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (922 citations), Virology (131 citations), Oncology (663 citations), Immunology (532 citations) and Genetics (155 citations). Karin Badel has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Gary Calandra, Gary Calandra, Gary Bridger, John F. DiPersio, Daniel J. Weisdorf, Jane L. Liesveld, Neal Flomenberg, Steven M. Devine, David H. Vesole and R. T. MacFarland. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Clinical Pharmacology & Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary CalandraBreakdown of academic impact, for papers by Paulo Vidal CampregherBreakdown of academic impact, for papers by Harry R. KoeneBreakdown of academic impact, for papers by Sherrie E. SchiffBreakdown of academic impact, for papers by Hong ZhengBreakdown of academic impact, for papers by C. GattringerBreakdown of academic impact, for papers by Friedrich SchueningBreakdown of academic impact, for papers by Douglas JoshuaBreakdown of academic impact, for papers by Toni B. SimonisBreakdown of academic impact, for papers by Janet Ayello